Buy Verastem Stock | VSTM Stock Price & Latest News | Public.com
VSTM

Verastem

$0.00 (0.00%)Today
    View Verastem (VSTM) stock trends here

    About VSTM

    Verastem, Inc., operating as Verastem Oncology, is a biopharmaceutical company focusing on developing and commercializing medicines to improve the survival and quality of life of cancer patients. It markets COPIKTRA™ (duvelisib), an oral inhibitor of phosphoinositide 3-...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0.08
    0.01
    -0.07
    -0.14
    Q2 2020
    Q3 2020
    Q4 2020
    Q1 2021

    Expected EPS
    Q1 2021

    -$0.09

    Actual EPS
    Q1 2021

    Stats

    Market Cap$387,08M
    Volume2,23k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$4.67
    1 Year Low$1.08
    Open$2.36
    High$2.40
    Low$2.27

    Buy any stock with any amount of money.

    Download the App
    Download the app